Industry News (Patents)

Patent Issued Covering Unique Approach to Transplantation and Blood Cell Cancers

Published in Blood Weekly, January 20th, 2000

BioTransplant Incorporated and its collaborator, The Massachusetts General Hospital (MGH), announced the award of a patent which covers BioTransplant's novel approach to transplantation and blood cell cancer treatments.

The US patent (no. 6006752), titled "Mixed Chimerism and Tolerance," was issued to Megan Sykes, MD, of MGH and licensed exclusively to BioTransplant. The technology covered in the patent is designed to re-educate a recipient's immune system to accept donor cells and organs as "self". The company believes this technology has the potential to expand the number of blood cell cancer and organ transplant patients who can be treated, produce fewer...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Blood Weekly

Source: Blood Weekly (2000-01-20)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry